- To complete this test successfully, answer all questions obtaining 10/10.
- You can repeat the test all the times you need but remember to answer all questions.
- You will require 30 minutes approximately to complete all the questions.
Test Summary
0 of 10 questions completed
Questions:
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
Information
You have already completed the test before. Hence you can not start it again.
Test is loading…
You must sign in or sign up to start the test.
You must first complete the following:
Results
Results
0 of 10 questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- Answered
- Review
-
Question 1 of 10
1. Question
Q1. Regarding TNBC please select the correct answer:
CorrectIncorrect -
Question 2 of 10
2. Question
Q2. Regarding the treatment of small TNBC tumors, please select the correct answer:
CorrectIncorrect -
Question 3 of 10
3. Question
Q3. Which of the following statements is included among the recommendations of some of the international clinical practice guidelines for the management of early BC:
CorrectIncorrect -
Question 4 of 10
4. Question
Q4. Select the incorrect statement regarding the principles of preoperative systemic therapy:
CorrectIncorrect -
Question 5 of 10
5. Question
Q5. Regarding the specific role of different chemotherapy regimens employed in early TNBC treatment please select the correct approach:
CorrectIncorrect -
Question 6 of 10
6. Question
Q6. Regarding the specific role of platinum-based chemotherapy in early TNBC treatment it is true that:
CorrectIncorrect -
Question 7 of 10
7. Question
Q7. Immune checkpoint inhibitors have been evaluated in the neoadjuvant setting of early TNBC treatment concluding that:
CorrectIncorrect -
Question 8 of 10
8. Question
Q8. In the adjuvant post-neoadjuvant setting for TNBC patients indicate the correct answer:
CorrectIncorrect -
Question 9 of 10
9. Question
Q9. All the patients bellow are candidates for 1 year adjuvant treatment with Olaparib based on the OlympiA trial results except for:
CorrectIncorrect -
Question 10 of 10
10. Question
Q10. Indicate the correct answer regarding the hereditary cancer testing criteria in patients with breast cancer:
CorrectIncorrect